301 related articles for article (PubMed ID: 21833527)
21. Role of Th1/Th2 cytokines in the diagnosis and prognostic evaluation of ankylosing spondylitis.
Wen JT; Zhang DH; Fang PF; Li MH; Wang RJ; Li SH
Genet Mol Res; 2017 Mar; 16(1):. PubMed ID: 28362980
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning.
Yılmaz O; Tutoğlu A; Garip Y; Ozcan E; Bodur H
Rheumatol Int; 2013 May; 33(5):1159-63. PubMed ID: 22955799
[TBL] [Abstract][Full Text] [Related]
23. Sexual Dimorphism in the Th17 Signature of Ankylosing Spondylitis.
Gracey E; Yao Y; Green B; Qaiyum Z; Baglaenko Y; Lin A; Anton A; Ayearst R; Yip P; Inman RD
Arthritis Rheumatol; 2016 Mar; 68(3):679-89. PubMed ID: 26473967
[TBL] [Abstract][Full Text] [Related]
24. Is the whole-body cryotherapy a beneficial supplement to exercise therapy for patients with ankylosing spondylitis?
Romanowski MW; Straburzyńska-Lupa A
J Back Musculoskelet Rehabil; 2020; 33(2):185-192. PubMed ID: 31594196
[TBL] [Abstract][Full Text] [Related]
25. Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS.
Yanik B; Gürsel YK; Kutlay S; Ay S; Elhan AH
Clin Rheumatol; 2005 Feb; 24(1):41-7. PubMed ID: 15365877
[TBL] [Abstract][Full Text] [Related]
26. Gender and disease features in Moroccan patients with ankylosing spondylitis.
Ibn Yacoub Y; Amine B; Laatiris A; Hajjaj-Hassouni N
Clin Rheumatol; 2012 Feb; 31(2):293-7. PubMed ID: 21796348
[TBL] [Abstract][Full Text] [Related]
27. Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis.
Inci U; Yildiz A; Batmaz I; Tekbas E
Int J Rheum Dis; 2017 Feb; 20(2):238-244. PubMed ID: 26012572
[TBL] [Abstract][Full Text] [Related]
28. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
[TBL] [Abstract][Full Text] [Related]
29. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
[TBL] [Abstract][Full Text] [Related]
30. Quality of life in patients with ankylosing spondylitis: relationships with spinal mobility, disease activity and functional status.
Ozdemir O
Rheumatol Int; 2011 May; 31(5):605-10. PubMed ID: 20049451
[TBL] [Abstract][Full Text] [Related]
31. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity.
Akkoc Y; Karatepe AG; Akar S; Kirazli Y; Akkoc N
Rheumatol Int; 2005 May; 25(4):280-4. PubMed ID: 14730386
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis.
Sari I; Bozkaya G; Kirbiyik H; Alacacioglu A; Ates H; Sop G; Can G; Taylan A; Piskin O; Yildiz Y; Akkoc N
J Rheumatol; 2012 Mar; 39(3):594-9. PubMed ID: 22247348
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis].
Xie J; Yu X
Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1300-4. PubMed ID: 26081658
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
Kim HR; Lee SH; Kim HY
Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
[TBL] [Abstract][Full Text] [Related]
35. Spinal mobility and its impact in Moroccan patients with ankylosing spondylitis.
Ibn Yacoub Y; Amine B; Laatiris A; Abouqal R; Hajjaj-Hassouni N
Clin Rheumatol; 2011 Feb; 30(2):239-43. PubMed ID: 21057838
[TBL] [Abstract][Full Text] [Related]
36. Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis.
Caso F; Costa L; Del Puente A; Rigante D; Selmi C; Fabbroni M; Scarpa R; Galeazzi M; Frediani B; Cantarini L
Clin Exp Rheumatol; 2015; 33(3):411-3. PubMed ID: 25962691
[TBL] [Abstract][Full Text] [Related]
37. Ankylosing spondylitis in Ireland: patient access and response to TNF-α blockers.
Saeed A; Khan M; Elmamoun M; Brady M; Morrissey S; Fraser AD
Rheumatol Int; 2012 May; 32(5):1305-9. PubMed ID: 21286722
[TBL] [Abstract][Full Text] [Related]
38. Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life.
Oktayoglu P; Em S; Tahtasiz M; Bozkurt M; Ucar D; Yazmalar L; Nas K; Yardımeden I; Cevik F; Celik Y; Mete N
Rheumatol Int; 2013 May; 33(5):1327-31. PubMed ID: 23143556
[TBL] [Abstract][Full Text] [Related]
39. Quality of life and correlation with clinical and radiographic variables in patients with ankylosing spondylitis: a retrospective case series study.
Huang JC; Qian BP; Qiu Y; Wang B; Yu Y; Zhu ZZ; Hu J; Qu Z
BMC Musculoskelet Disord; 2017 Aug; 18(1):352. PubMed ID: 28810915
[TBL] [Abstract][Full Text] [Related]
40. Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis.
Bal A; Unlu E; Bahar G; Aydog E; Eksioglu E; Yorgancioglu R
Clin Rheumatol; 2007 Feb; 26(2):211-5. PubMed ID: 16583185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
